Your search returned 2 results.

Results
	1.	A randomized, double-blind, placebo-controlled trial of CDP571, a humanized monoclonal antibody to tumour necrosis factor-alpha, in patients with corticosteroid-dependent Crohn's disease. [electronic resource] by Feagan, B G Sandborn, W J Baker, J P Cominelli, F Sutherland, L R Elson, C O Salzberg, B A Archambault, A Bernstein, C N Lichtenstein, G R Heath, P K Cameron, S Hanauer, S B Producer: 20050524 In: Alimentary pharmacology & therapeutics vol. 21 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Daclizumab, a humanised monoclonal antibody to the interleukin 2 receptor (CD25), for the treatment of moderately to severely active ulcerative colitis: a randomised, double blind, placebo controlled, dose ranging trial. [electronic resource] by Van Assche, G Sandborn, W J Feagan, B G Salzberg, B A Silvers, D Monroe, P S Pandak, W M Anderson, F H Valentine, J F Wild, G E Geenen, D J Sprague, R Targan, S R Rutgeerts, P Vexler, V Young, D Shames, R S Producer: 20061114 In: Gut vol. 55 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)

Refine your search